Physician profile
David Nash
NPI 1023043171
$2,488.85
in general payments reported to CMS, 2019-2025
16 companies · $307 in 2025
The $307 reported for 2025 was more than what 78% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,005 · 2020: $228 · 2021: $144 · 2022: $194 · 2023: $332 · 2024: $279 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $899 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $898.72 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $622.98 | 2022-2025 | Ganirelix Acetate, Pregnyl, Follistim Aq |
| Ferring Pharmaceuticals INC. | $310.22 | 2019-2025 | Menopur |
| Merck Sharp & Dohme LLC | $255.62 | 2019-2021 | |
| Coopersurgical, INC. | $251.79 | 2020-2024 | Stripper |
| Abbvie INC. | $251.05 | 2019-2020 | |
| Hologic Sales and Service, LLC | $184.62 | 2019 | |
| Emd Serono, INC. | $127.36 | 2019 | |
| Tesaro, INC. | $125.00 | 2019 | |
| Medical Device Business Services, INC. | $116.75 | 2019 | |
| Avion Pharmaceuticals | $94.60 | 2019-2020 | |
| Myovant Sciences INC. | $39.98 | 2021-2022 | |
| Minerva Surgical, INC | $27.79 | 2022-2024 | |
| Vertical Pharmaceuticals, LLC | $27.22 | 2019 | |
| Meditrina | $20.89 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $19.27 | 2023 | Myfembree |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $13.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Nash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.